Skip to content

Clinical trials

Phase 2 Muscle Spasticity trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscle Spasticity Phase: Phase 2 Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20041
20061
20072
20091
20131
20141
20151
20211
20221
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting2
Active, not recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan3
Acorda Therapeutics2
Alberto Esquenazi1
Avigen1
Celgene1
Duke University1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Impax Laboratories, LLC1
Johns Hopkins University1
Michael, Levy M.D.,Ph.D.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscle Spasticity17
Multiple Sclerosis5
Stroke5
Cerebral Palsy2
Motor Neuron Disease2
Amyotrophic Lateral Sclerosis1
Marijuana Abuse1
Muscle Cramp1
Muscular Atrophy, Spinal1
Nervous System Diseases1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.